Has Amy Dice received payments from drug or device companies?

Yes. Drug and device makers reported $2,846 in general payments to Amy Dice across 150 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amy Dice did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amy Dice come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amy Dice

Psychiatric/Mental Health · Milwaukee, WINPI 1245011311

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,718, 10.0 times the $172 reported in 2023.

$2,846in general payments, 2019–2025

Across 150 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Tris Pharma Inc$570
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$531
Axsome Therapeutics, Inc.$463
Johnson & Johnson$437
AbbVie$298
Vanda Pharmaceuticals Inc.$270
plus $278 from 8 others

What the payments were for

Food & beverage$2,79198%
Education$562%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Tris Pharma Inc	33	$570
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	25	$531
Axsome Therapeutics, Inc.	25	$463
Johnson & Johnson	15	$437
AbbVie	14	$298
Vanda Pharmaceuticals Inc.	18	$270
Takeda Pharmaceuticals U.S.A., Inc.	6	$88
Alkermes, Inc.	3	$64
Corium, LLC	6	$44
Neos Therapeutics, LP	1	$21
Lundbeck LLC	1	$18
Otsuka America Pharmaceutical, Inc.	1	$15
Collegium Pharmaceutical, Inc.	1	$14
Bausch Health US, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,846 in reported general payments places this provider in the 85th percentile of 384 psychiatric/mental health providers in Wisconsin.

See all psychiatric/mental health providers in Wisconsin →

Other psychiatric/mental health in Milwaukee

Carolyn DavidsonMilwaukee$46K
Sherry AleksichMilwaukee$33K
Ngozi ObioraMilwaukee$19K
Victoria McGinleyMilwaukee$9K
Andrea MitchellMilwaukee$6K
Angeline VercauterenMilwaukee$6K
Lisa CwiklaMilwaukee$5K
Julia JasterMilwaukee$5K
Angelia Felton-WilksMilwaukee$4K
Kristen AndersonMilwaukee$4K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →